Frits I. Mulder

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Tumor Whole-Genome Sequencing for Prediction of Venous Thromboembolism in Patients With Metastasized Solid Cancer.

Tumor Whole-Genome Sequencing for Prediction of Venous Thromboembolism in Patients With Metastasized Solid Cancer.

Journal: Circulation. Genomic and precision medicine

Published: April 10, 2026

Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseases.

Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseases.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: August 20, 2025

Absolute quantitative proteomics identifies patterns of plasma proteins associated with venous thromboembolism in patients with colorectal cancer.

Absolute quantitative proteomics identifies patterns of plasma proteins associated with venous thromboembolism in patients with colorectal cancer.

Journal: Thrombosis research

Published: June 13, 2025

Quantitative targeted proteomics for occult cancer screening in patients with unprovoked venous thromboembolism: results from the prospective PLATO-VTE study.

Quantitative targeted proteomics for occult cancer screening in patients with unprovoked venous thromboembolism: results from the prospective PLATO-VTE study.

Journal: Research and practice in thrombosis and haemostasis

Published: May 22, 2025

Validation of clinical risk assessment scores for venous thromboembolism in patients with cancer: a population-based cohort study: Reply.

Validation of clinical risk assessment scores for venous thromboembolism in patients with cancer: a population-based cohort study: Reply.

Journal: Journal of thrombosis and haemostasis : JTH

Published: February 25, 2025

Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort study.

Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort study.

Journal: EClinicalMedicine

Published: December 23, 2024

Validation of clinical risk assessment scores for venous thromboembolism in patients with cancer: a population-based cohort study.

Validation of clinical risk assessment scores for venous thromboembolism in patients with cancer: a population-based cohort study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: April 30, 2024

Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study.

Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 13, 2023

Disclosure of Prediction Model.

Disclosure of Prediction Model.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 10, 2023

Risk of Cardiovascular Disease in Cancer Survivors after Systemic Treatment: A Population-Based Cohort Study.

Risk of Cardiovascular Disease in Cancer Survivors after Systemic Treatment: A Population-Based Cohort Study.

Journal: JACC. CardioOncology

Published: August 18, 2023

RNA-sequencing to discover genes and signaling pathways associated with venous thromboembolism in glioblastoma patients: A case-control study.

RNA-sequencing to discover genes and signaling pathways associated with venous thromboembolism in glioblastoma patients: A case-control study.

Journal: Thrombosis research

Published: July 27, 2023

Effect of the P-glycoprotein inhibitor tamoxifen on edoxaban plasma levels in women with breast cancer.

Effect of the P-glycoprotein inhibitor tamoxifen on edoxaban plasma levels in women with breast cancer.

Journal: Thrombosis research

Published: April 08, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026